Literature DB >> 6142267

Regression of Kaposi's sarcoma in AIDS after treatment with dapsone.

A Poulsen, B Hultberg, K Thomsen, G L Wantzin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6142267     DOI： 10.1016/s0140-6736(84)90949-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Dapsone as an Immunomodulator In Vivo Using the Tuberculin Skin Test as a Parameter.

Authors:  J R Snyman; W K Jacyk; D J Lizamore; K De Sommers
Journal:  Clin Drug Investig       Date:  1995-09       Impact factor: 2.859

Review 2.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

3.  The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.

Authors:  M D Coleman; L E Rhodes; A K Scott; J L Verbov; P S Friedmann; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.